Management of Non-Muscle Invasive Bladder Cancer

This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.

Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.

Cover

Front Matter

 Part I. Background and Pathology on Bladder Cancer



1. Background on Bladder Cancer



2. Introduction to Bladder Cancer Type and Therapy

 Part II. Histological Variants in Bladder Cancer



3. Histological Variants in Bladder Cancer—Sqaumous Cell Carcinoma and Squamous Differentiation



4. Histological Variants in Bladder Cancer—Adenocarcinoma



5. Histological Variants in Bladder Cancer—Sarcomatoid Differentiation



6. Histological Variants in Bladder Cancer—Carcinosarcoma



7. Histological Variants in Bladder Cancer—Small Cell Carcinoma



8. Histological Variants—Plasmacytoid Bladder Cancer

 Part III. Epidemiology and Risk Factors in Bladder Cancer



9. Introduction to Epidemiology of Bladder Cancer



10. Epidemiology, Risk Factors and Occupational Hazards—A Systematic Review



11. Systematic Review Results on Bladder Cancer Epidemiology, Occupational Hazards and Risk Factors

 Part IV. Assessment and Diagnostics in NMIBC



12. Bladder Cancer—Diagnostic Pathways



13. Systematic Review Method—Bladder Cancer Screening



14. Bladder Cancer Screening—Systematic Review Results



15. Bladder Cancer Screening Systematic Review Conclusion



16. Statement of Main Findings and Specific Areas of Unmet Needs Arising from Systematic Review on Bladder Cancer Screening



17. Usefulness of Screening in Bladder Cancer

 Part V. Techniques in Endoscopic Resection



18. Management of Non-Muscle Invasive Bladder Cancer



19. A New Technique—En Bloc Resection of Bladder Tumours



20. Prognostic Factors for Endoscopic Resection in NMIBC



21. NMIBC and Oncological Outcomes from Endoscopic Resection



22. Recurrence in NMIBC



23. Definitive Treatment in NMIBC



24. A Systematic Review of En-Bloc Resection



25. Systematic Review—Results from En-Bloc Resection of Bladder Cancer

 Part VI. Management of Low and Intermediate Risk Bladder Cancer



26. NMIBC—Fulguration in Low Risk Disease



27. Active Surveillance in Non-Muscle Invasive Bladder Cancer



28. Hyperthermic MMC—A Systematic Review



29. Literature Related to Hyperthermic MMC

 Part VII. Management of High Risk Non-Muscle Invasive Bladder Cancer



30. BCG—Patterns of Administration



31. NMIBC—BCG Strain and Outcomes



32. Adverse Effects in BCG Therapy



33. BCG and Elderly Patients



34. A Systematic Review of NMIBC and Intravesical Chemotherapy



35. A Systematic Review of NMIBC and Intravesical Chemotherapy—Results



36. What the Literature Says Re BCG



37. Prognostic Factors in BCG



38. Intermediate and High Risk NMIBC and BCG



39. NMIBC, Low Dose BCG and High-Risk Disease



40. Alternatives to BCG Therapy—MMC



41. BCG Versus Mitomycin C—A Systematic Review



42. What the Literature Says NMIBC—BCG or MMC



43. NMIBC and Intravesical Chemotherapy—HIVEC I and HIVEC II



44. BCG Refractory Disease—Oncological Outcomes



45. NMIBC—High Grade BCG Refractory Disease



46. A Systematic Review on Alternatives in BCG Refractory Disease



47. Systematic Review Results on BCG Refractory Disease Management



48. What the Literature Says on BCG Refractory Disease and Alternatives



49. NMIBC—BCG Refractory Disease and Use of Interferon



50. Novel Agents in BCG Refractory Disease



51. A Scoring System for Intravesical Therapy and NMIBC



52. High Risk NMIBC and TURBT



53. G3T1 Bladder Cancer: Cystectomy Versus BCG



54. A Systematic Review of High-Grade Bladder Cancer—Methods



55. Systematic Review of G3T1 Bladder Cancer



56. Radical Cystectomy in High Grade NMI Bladder Cancer

 Part VIII. Bladder Cancer in the Elderly and Females



57. Bladder Cancer in the Elderly



58. Systematic Review on Bladder Cancer Management in Elderly Patients



59. Systematic Review—Results on Bladder Cancer Management in the Elderly



60. Reviews Relating to Management of Bladder Cancer in the Elderly



61. Female Outcomes in Bladder Cancer



62. A Systematic Review on Bladder Cancer and Female Gender



63. Systematic Review Results on Bladder Cancer and Female Gender



64. Reviews on Female Gender and Bladder Cancer

 Part IX. Bladder Cancer Survivorship



65. Definition of Bladder Cancer Survivorship



66. The Impact of Bladder Cancer Survivorship



67. Unmet Needs in Bladder Cancer Survivorship



68. Systematic Review—Bladder Cancer Survivorship—Unmet Needs



69. Systematic Review Search Results—Bladder Cancer Survivorship and Unmet Need



70. Survivorship Challenges in Non-Muscle Invasive Bladder Cancer



71. Bladder Cancer Survivorship Care Plans



72. Research Summary—A New Model of Care for Patients with Bladder Cancer (MODA)



73. What Is the Impact of Sexual and Emotional Concerns on Patients Post Surgery for Patients with Bladder Cancer?



74. Results—Telephone Interviews with Thematic Analyses



75. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 1 Erectile Dysfunction



76. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 2 Age Related Disease



77. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 3 Side Effects Post Operatively



78. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 4 Psychological Impact



79. Bladder Cancer Survivorship and Patient Reported Outcome Measures—Code 5 Impact of Operation on General Health



80. Bladder Cancer Survivorship Tool



81. Health Related Quality of Life Measurements in Bladder Cancer Survivorship

Back Matter